Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 19 results.
User Information
Export Records
  1. 1.   Apoptosis Is the Essential Target of Selective Pressure against p53, whereas Loss of Additional p53 Functions Facilitates Carcinoma Progression
  2. Lu, X. D. L. X. D.; Yang, C. Y.; Yin, C. Y.; Van Dyke, T.; Simin, K.
  3. Molecular Cancer Research. 2011, Apr; 9(4): 430-439.
  1. 2.   Histone Deacetylase Inhibitors Prevent p53-Dependent and p53-Independent Bax-Mediated Neuronal Apoptosis through Two Distinct Mechanisms
  2. Uo, T.; Veenstra, T. D.; Morrison, R. S.
  3. Journal of Neuroscience. 2009 29(9): 2824-2832.
  1. 3.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 4.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 5.   p53 translocation to mitochondria precedes its nuclear translocation and targets mitochondrial oxidative defense protein-manganese superoxide dismutase
  2. Zhao, Y. F.; Chaiswing, L.; Velez, J. M.; Batinic-Haberle, I.; Colburn, N. H.; Oberley, T. D.; St Clair, D. K.
  3. Cancer Research. 2005, MAY 1; 65(9): 3745-3750.
  1. 6.   Regulating the p53 system through ubiquitination
  2. Yang, Y. L.; Li, C. C. H.; Weissman, A. M.
  3. Oncogene. 2004 23(11): 2096-2106.
  1. 7.   Apocytochrome c blocks caspase-9 activation and Bax-induced apoptosis
  2. Martin, A. G.; Fearnhead, H. O.
  3. Journal of Biological Chemistry. 2002 277(52): 50834-50841.
  1. 8.   Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243-and 289-amino-acid proteins
  2. Yang, Y. P.; McKerlie, C.; Borenstein, S. H.; Lu, Z.; Schito, M.; Chamberlain, J. W.; Buchwald, M.
  3. Journal of Virology. 2002 76(17): 8910-8919.
  1. 9.   Live or let die: The cell's response to p53
  2. Vousden, K. H.; Lu, X.
  3. Nature Reviews Cancer. 2002 2(8): 594-604.
  1. 10.   E2F-1 induced apoptosis
  2. Phillips, A. C.; Vousden, K. H.
  3. Apoptosis. 2001 6(3): 173-182.
  1. 11.   PUMA, a novel proapoptotic gene, is induced by p53
  2. Nakano, K.; Vousden, K. H.
  3. Molecular Cell. 2001 7(3): 683-694.
  1. 12.   Molecular cloning of ILP-2, a novel member of the inhibitor of apoptosis protein family
  2. Richter, B. W. M.; Mir, S. S.; Eiben, L. J.; Lewis, J.; Reffey, S. B.; Frattini, A.; Tian, L.; Frank, S.; Youle, R. J.; Nelson, D. L.; Notarangelo, L. D.; Vezzoni, P.; Fearnhead, H. O.; Duckett, C. S.
  3. Molecular and Cellular Biology. 2001 21(13): 4292-4301.
  1. 13.   Regulation and function of the p53 tumor suppressor protein
  2. Ryan, K. M.; Phillips, A. C.; Vousden, K. H.
  3. Current Opinion in Cell Biology. 2001 13(3): 332-337.
  1. 14.   Role for the p53 homologue p73 in E2F-1-induced apoptosis
  2. Irwin, M.; Marin, M. C.; Phillips, A. C.; Seelan, R. S.; Smith, D. I.; Liu, W. G.; Flores, E. R.; Tsai, K. Y.; Jacks, T.; Vousden, K. H.; Kaelin, W. G.
  3. Nature. 2000 407(6804): 645-648.
  1. 15.   Role of NF-kappa B in p53-mediated programmed cell death
  2. Ryan, K. M.; Ernst, M. K.; Rice, N. R.; Vousden, K. H.
  3. Nature. 2000 404(6780): 892-897.
  1. 16.   The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis
  2. Koo, H. M.; Gray-Goodrich, M.; Kohlhagen, G.; McWilliams, M. J.; Jeffers, M.; Vaigro-Wolff, A.; Alvord, W. G.; Monks, A.; Paull, K. D.; Pommier, Y.; Vande Woude, G. F.
  3. Journal of the National Cancer Institute. 1999 91(3): 236-244.
  1. 17.   Regulation and activation of p53 and its family members
  2. Lohrum, M. A. E.; Vousden, K. H.
  3. Cell Death and Differentiation. 1999 6(12): 1162-1168.
  1. 18.   Characterization of Structural P53 Mutants Which Show Selective Defects in Apoptosis But Not Cell Cycle Arrest
  2. Ryan, K. M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(7): 3692-3698.
  1. 19.   Regulation of Mdm2-Directed Degradation By the C Terminus of P53
  2. Kubbutat, M. H. G.; Ludwig, R. L.; Ashcroft, M.; Vousden, K. H.
  3. Molecular and Cellular Biology. 1998 18(10): 5690-5698.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel